
CBL-514
Research Peptide | Lyophilized Powder | Batch Tested
For laboratory research use only. Not for human or animal consumption. Insulated shipping · Styrofoam box available.
Product Overview
CBL-514 is an injectable small-molecule compound studied for its ability to induce apoptosis selectively in fat cells. Unlike detergent- or heat-based approaches, it is designed to trigger programmed adipocyte death in a dose-dependent manner, making it a research tool for localized adipose reduction.
| Test | Result | Status |
|---|---|---|
| Purity | 98.8% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 98.7% | Passed ✓ |
| Test | Result | Status |
|---|---|---|
| Purity | 99.0% | Passed ✓ |
Research Information
CBL-514 is used in adipose-biology research to study dose-dependent adipocyte apoptosis and the downstream clearance of fat cells in cell and animal models. Research focuses on its selectivity for adipocytes and the local tissue response, distinguishing apoptosis-driven fat reduction from lytic or thermal mechanisms. Supplied strictly for in-vitro and laboratory research use only — not for human or animal consumption.
CBL-514 Research & Studies
What is CBL-514?
CBL-514 is a small-molecule compound examined in laboratory settings for its capacity to induce programmed cell death selectively in adipocytes. Research frameworks position it as a tool for probing localized adipose reduction through apoptosis rather than detergent-mediated lysis or thermal injury. Investigations typically employ cell culture systems and controlled animal models to characterize its dose-dependent effects on fat cells. Material is supplied exclusively for in-vitro and laboratory research use.
Mechanism of Action
Studies indicate that CBL-514 engages pathways leading to apoptosis within mature adipocytes in a concentration-dependent fashion. Unlike agents that disrupt membranes nonspecifically, the compound is evaluated for preferential activation of programmed death cascades in lipid-laden cells. Downstream research tracks clearance of apoptotic adipocytes by surrounding tissue responses in model systems. Mechanistic work focuses on distinguishing this apoptotic route from lytic or heat-based alternatives.
Primary Areas of Research
Primary investigations center on adipose-biology models that quantify selective adipocyte apoptosis and subsequent cellular clearance. Researchers utilize CBL-514 to compare apoptosis-driven fat-cell reduction against detergent or thermal approaches in controlled experimental designs. Work also examines local tissue responses and selectivity profiles across different cell populations in vitro and in animal models. These studies aim to map dose relationships and temporal patterns of adipocyte loss under laboratory conditions.
Key Research Findings
Laboratory observations report that CBL-514 can trigger dose-dependent apoptosis in adipocytes within cell-based assays and selected animal models. Findings emphasize relative selectivity for fat cells compared with certain non-adipocyte populations under the tested conditions. Research further documents the progression from apoptotic induction to clearance of residual cellular material in localized tissue environments. Results are framed strictly as experimental outcomes rather than applied outcomes.
Research Handling & Considerations
CBL-514 is handled under standard laboratory protocols for small-molecule research reagents, including appropriate storage and preparation for in-vitro or model-system work. Investigators note the importance of precise concentration control when studying dose-response relationships in adipocyte cultures. Experimental designs typically incorporate controls that differentiate apoptotic markers from nonspecific cytotoxicity. All use remains confined to research environments and excludes any form of consumption or application outside laboratory models.
Frequently Asked Questions
CBL-514 is examined primarily in adipocyte cell cultures and controlled animal models that allow measurement of apoptosis and tissue clearance.
Explore Other High-Purity Peptides

Semaglutide

Tirzepatide

Retatrutide
